CA Patent

CA2989469A1 — 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones

Assigned to Bayer Pharma AG · Expires 2016-12-22 · 9y expired

What this patent protects

Compounds of formula (I) as described hereinprocesses for their production and their use as anti-cancer agents.

USPTO Abstract

Compounds of formula (I) as described hereinprocesses for their production and their use as anti-cancer agents.

Drugs covered by this patent

Patent Metadata

Patent number
CA2989469A1
Jurisdiction
CA
Classification
—
Expires
2016-12-22
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Pharma AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.